Mark Roberge scaled HubSpot from $0 to $100M+ ARR as CRO, led its IPO, then joined Kleiner Perkins as a partner while teaching a popular sales course at HBS. He founded Stage 2 Capital (a $100M fund backed by 1,000+ CROs/CMOs) and recently launched Roadrunner, an AI-native CPQ startup backed by Founders Fund. Author of 'The Science of Scaling.'
no scored calls yet — needs a stated position or a categorical verdict, with a matured window vs SPY
Stage 2 Capital's LP base of 1,000+ sales and marketing executives creates a unique go-to-market value-add platform for portfolio companies across any B2B sector, differentiating the fund in pre-seed/seed investing.
CPQ is a misunderstood, mission-critical category where incumbents have rigid data models that can't handle modern pricing; AI enables flexible reasoning over price/rule books, and the vendor assumes liability for quote accuracy creating a 'CYA' accountability moat that drives enterprise trust and adoption.
Founders Fund's persistence and track record (incubating Anduril, early in Rippling/Figma/Slack) signaled deep understanding of messy early-stage scaling, making them the right partner despite Mark's initial instinct to delay fundraising until more contracts closed.